Clinical trial NCT04923360 - References

COPD — Morphological Parameters of Blood Cell's Activation in Characterization and Prognosis in a COPD Patients Cohort

Citation(s)

•   Arostegui I, Esteban C, García-Gutierrez S, Bare M, Fernández-de-Larrea N, Briones E, Quintana JM; IRYSS-COPD Group
  Subtypes of patients experiencing exacerbations of COPD and associations with outcomes. PLoS One. 2014 Jun 3;9(6):e98580. doi: 10.1371/journal.pone.0098580. eCollection 2014.
•   Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, Haldar P, McCormick M, Haldar K, Kebadze T, Duvoix A, Lindblad K, Patel H, Rugman P, Dodson P, Jenkins M, Saunders M, Newbold P, Green RH, Venge P, Lomas DA, Barer MR, Johnston SL, Pavord ID, Brightling CE
  Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011 Sep 15;184(6):662-71. doi: 10.1164/rccm.201104-0597OC.
•   Bafadhel M, Pavord ID, Russell REK
  Eosinophils in COPD: just another biomarker? Lancet Respir Med. 2017 Sep;5(9):747-759. doi: 10.1016/S2213-2600(17)30217-5. Epub 2017 Jun 7. Review. Erratum in: Lancet Respir Med. 2017 Aug;5(8):e28.
•   Buoro S, Seghezzi M, Vavassori M, Dominoni P, Apassiti Esposito S, Manenti B, Mecca T, Marchesi G, Castellucci E, Azzarà G, Ottomano C, Lippi G
  Clinical significance of cell population data (CPD) on Sysmex XN-9000 in septic patients with our without liver impairment. Ann Transl Med. 2016 Nov;4(21):418.
•   Cornet E, Boubaya M, Troussard X
  Contribution of the new XN-1000 parameters NEUT-RI and NEUT-WY for managing patients with immature granulocytes. Int J Lab Hematol. 2015 Oct;37(5):e123-6. doi: 10.1111/ijlh.12372. Epub 2015 Apr 28.
•   Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA
  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002 Oct;57(10):847-52. Erratum in: Thorax. 2008 Aug;63(8):753.
•   Esteban C, Quintana JM, Moraza J, Aburto M, Egurrola M, España PP, Pérez-Izquierdo J, Aguirre U, Aizpiri S, Capelastegui A
  Impact of hospitalisations for exacerbations of COPD on health-related quality of life. Respir Med. 2009 Aug;103(8):1201-8. doi: 10.1016/j.rmed.2009.02.002. Epub 2009 Mar 9.
•   García-Rivero JL, Esquinas C, Barrecheguren M, Bonnin-Vilaplana M, García-Sidro P, Herrejón A, Martinez-Rivera C, Malo de Molina R, Marcos PJ, Mayoralas S, Naval E, Ros JA, Valle M, Miravitlles M
  Risk Factors of Poor Outcomes after Admission for a COPD Exacerbation: Multivariate Logistic Predictive Models. COPD. 2017 Apr;14(2):164-169. doi: 10.1080/15412555.2016.1260538. Epub 2016 Dec 16.
•   Henriot I, Launay E, Boubaya M, Cremet L, Illiaquer M, Caillon H, Desjonquères A, Gillet B, Béné MC, Eveillard M
  New parameters on the hematology analyzer XN-10 (SysmexTM) allow to distinguish childhood bacterial and viral infections. Int J Lab Hematol. 2017 Feb;39(1):14-20. doi: 10.1111/ijlh.12562. Epub 2016 Aug 30.
•   Kaeslin M, Brunner S, Raths J, Huber A
  Improvement in detecting bacterial infection in lower respiratory tract infections using the Intensive Care Infection Score (ICIS). J Lab Med 2016; 40: 175-182.
•   Kerkhof M, Sonnappa S, Postma DS, Brusselle G, Agustí A, Anzueto A, Jones R, Papi A, Pavord I, Pizzichini E, Popov T, Roche N, Ryan D, Thomas M, Vogelmeier C, Chisholm A, Freeman D, Bafadhel M, Hillyer EV, Price DB
  Blood eosinophil count and exacerbation risk in patients with COPD. Eur Respir J. 2017 Jul 20;50(1). pii: 1700761. doi: 10.1183/13993003.00761-2017. Print 2017 Jul.
•   Linssen J, Aderhold S, Nierhaus A, Frings D, Kaltschmidt C, Zänker K
  Automation and validation of a rapid method to assess neutrophil and monocyte activation by routine fluorescence flow cytometry in vitro. Cytometry B Clin Cytom. 2008 Sep;74(5):295-309. doi: 10.1002/cyto.b.20422.
•   Mathers CD, Loncar D
  Updated projections of global mortality and burden of disease, 2002-2030.World Health Organization, http//www.who.int/healthinfo/statistics/bodprojectionspaper.pdf.
•   Paliogiannis P, Fois AG, Sotgia S, Mangoni AA, Zinellu E, Pirina P, Negri S, Carru C, Zinellu A
  Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives. Eur Respir Rev. 2018 Feb 7;27(147). pii: 170113. doi: 10.1183/16000617.0113-2017. Print 2018 Mar 31. Review.
•   Pascoe S, Locantore N, Dransfield MT, Barnes NC, Pavord ID
  Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med. 2015 Jun;3(6):435-42. doi: 10.1016/S2213-2600(15)00106-X. Epub 2015 Apr 12. Erratum in: Lancet Respir Med. 2015 Jun;3(6):e19.
•   Romundstad S, Naustdal T, Romundstad PR, Sorger H, Langhammer A
  COPD and microalbuminuria: a 12-year follow-up study. Eur Respir J. 2014 Apr;43(4):1042-50. doi: 10.1183/09031936.00160213. Epub 2014 Jan 16.
•   Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, Salcedo E, Navarro M, Ochando R
  Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005 Nov;60(11):925-31. Epub 2005 Jul 29.
•   Urrechaga E, Bóveda O, Aguirre U
  Role of leucocytes cell population data in the early detection of sepsis. J Clin Pathol. 2018 Mar;71(3):259-266. doi: 10.1136/jclinpath-2017-204524. Epub 2017 Aug 18.
•   Vedel-Krogh S, Nielsen SF, Lange P, Vestbo J, Nordestgaard BG
  Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study. Am J Respir Crit Care Med. 2016 May 1;193(9):965-74. doi: 10.1164/rccm.201509-1869OC.
•   World Health Organization
  Chronic Obstructive Pulmonary Disease (COPD). Avalaible from: http:// www.who.int/respiratory/copd/en/index.html
•   Xu D
  Clinical Applications of Leukocyte Morphological Parameters Int J Pathol Clin Res 2015; 1:002
•   Yao C, Liu X, Tang Z
  Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD. Int J Chron Obstruct Pulmon Dis. 2017 Aug 3;12:2285-2290. doi: 10.2147/COPD.S141760. eCollection 2017.
•   Yoon HI, Li Y, Man SFP, Tashkin D, Wise RA, Connett JE, Anthonisen NA, Churg A, Wright JL, Sin DD
  The complex relationship of serum adiponectin to COPD outcomes COPD and adiponectin. Chest. 2012 Oct;142(4):893-899. doi: 10.1378/chest.11-2173.
•   Zemans RL, Jacobson S, Keene J, Kechris K, Miller BE, Tal-Singer R, Bowler RP
  Multiple biomarkers predict disease severity, progression and mortality in COPD. Respir Res. 2017 Jun 13;18(1):117. doi: 10.1186/s12931-017-0597-7.
•   Zhu Y, Cao X, Tao G, Xie W, Hu Z, Xu D
  The lymph index: a potential hematological parameter for viral infection. Int J Infect Dis. 2013 Jul;17(7):e490-3. doi: 10.1016/j.ijid.2012.12.002. Epub 2013 Jan 10.

Morphological Parameters of Blood Cell's Activation in Characterization and Prognosis in a COPD Patients Cohort

Details for clinical trial NCT04923360